Comment re: Temozolomide preferentially depletes cancer stem cells
- PMID: 19622770
- DOI: 10.1158/0008-5472.CAN-09-0036
Comment re: Temozolomide preferentially depletes cancer stem cells
Comment on
-
Temozolomide preferentially depletes cancer stem cells in glioblastoma.Cancer Res. 2008 Jul 15;68(14):5706-15. doi: 10.1158/0008-5472.CAN-07-6878. Cancer Res. 2008. PMID: 18632623
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical